iBio, Inc. — Director's Dealing 2017

Apr 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2014-09-05

Reporting Person: GIANNONE MARK A (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-05	Stock Option (right to buy)	$0.49	A	50000	Acquired	2024-09-05	Common Stock (50000)	Direct
2015-09-04	Stock Option (right to buy)	$1.72	A	150000	Acquired	2025-09-04	Common Stock (150000)	Direct

Footnotes

F1: (1) Vesting starts 7/1/2014, in equal annual installments over three years.

F2: (2) Vesting starts 7/1/2015, in equal annual installments over three years.